Bright Minds Biosciences holds annual shareholder meeting
DRUG•Bright Minds Biosciences held its annual general meeting on March 31, 2026, where shareholders backed six director nominees and appointed De Visser Gray LLP as auditor.
1. Meeting results
Shareholders at Bright Minds Biosciences’ annual general meeting on March 31, 2026, backed the six director nominees, confirming the board slate. De Visser Gray LLP was appointed as the company’s auditor.
